NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
16 hedge funds and large institutions have $1.6M invested in NeuroMetrix, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
6% less funds holding
Funds holding: 17 → 16 (-1)
23% less capital invested
Capital invested by funds: $2.07M → $1.6M (-$475K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$120K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$36.5K |
| 3 |
Millennium Management
New York
|
+$34.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$9.96K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$71.3K |
| 2 |
Renaissance Technologies
New York
|
-$54.6K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$44K |
| 4 |
Morgan Stanley
New York
|
-$522 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $977K | +$120K | +4,362 | +11% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $154K | +$1.81K | +66 | +1% |
|
3
BlackRock
New York
| $106K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $97K | +$36.5K | +1,331 | +44% |
|
|
5
Renaissance Technologies
New York
| $79K | -$54.6K | -1,989 | -36% |
|
6
State Street
Boston,
Massachusetts
| $51K | – | – | – |
|
7
Northern Trust
Chicago,
Illinois
| $31K | – | – | – |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $28K | – | – | – |
|
|
9
Millennium Management
New York
| $28K | +$34.8K | +1,268 | New |
|
|
10
Bank of America
Charlotte,
North Carolina
| $26K | -$71.3K | -2,598 | -69% |
|
|
11
UBS Group
Zurich,
Switzerland
| $9K | +$9.96K | +363 | +698% |
|
|
TAM
12
Tucker Asset Management
Littleton,
Colorado
| $6.02K | – | – | – |
|
|
SC
13
Stephens Consulting
Flint,
Michigan
| $1.4K | – | – | – |
|
|
IA
14
IFP Advisors
Tampa,
Florida
| $1K | – | – | – |
|
|
TRCT
15
Tower Research Capital (TRC)
New York
| $1K | +$741 | +27 | New |
|
|
TSS
16
Two Sigma Securities
New York
| – | -$44K | -1,485 | Closed |
|
|
17
Morgan Stanley
New York
| – | -$522 | -19 | Closed |
|
NURO Hedge Fund Activity: Q3 2022 in Review
16 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q3 2022, worth a combined $1.6M — down 23% from $2.07M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NURO and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.
The largest buyer was Vanguard Group, adding an estimated $120K. The largest seller was Bank of America, cutting an estimated $71.3K.
- 16 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q3 2022, down from 17 in Q2 2022.
- Funds reported $1.6M of NeuroMetrix, Inc. Common Stock stock for Q3 2022, down 23% quarter-over-quarter.
- 2 funds opened new NeuroMetrix, Inc. Common Stock positions in Q3 2022 and 3 closed out, a net change of -1 holder.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q3 2022 was Vanguard Group, an estimated $120K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q3 2022 was Bank of America, an estimated $71.3K sold.
Based on aggregated 13F filings for Q3 2022.